Department of Chemical and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Mol Syst Biol. 2013;9:649. doi: 10.1038/msb.2013.5.
We evaluated the presence/absence of proteins encoded by 14 077 genes in adipocytes obtained from different tissue samples using immunohistochemistry. By combining this with previously published adipocyte-specific proteome data, we identified proteins associated with 7340 genes in human adipocytes. This information was used to reconstruct a comprehensive and functional genome-scale metabolic model of adipocyte metabolism. The resulting metabolic model, iAdipocytes1809, enables mechanistic insights into adipocyte metabolism on a genome-wide level, and can serve as a scaffold for integration of omics data to understand the genotype-phenotype relationship in obese subjects. By integrating human transcriptome and fluxome data, we found an increase in the metabolic activity around androsterone, ganglioside GM2 and degradation products of heparan sulfate and keratan sulfate, and a decrease in mitochondrial metabolic activities in obese subjects compared with lean subjects. Our study hereby shows a path to identify new therapeutic targets for treating obesity through combination of high throughput patient data and metabolic modeling.
我们使用免疫组织化学方法评估了来自不同组织样本的脂肪细胞中 14077 个基因编码的蛋白质的存在/缺失情况。通过将此结果与之前发表的脂肪细胞特异性蛋白质组数据相结合,我们确定了与人类脂肪细胞中 7340 个基因相关的蛋白质。这些信息被用于重建脂肪细胞代谢的综合且功能齐全的基因组规模代谢模型。由此产生的代谢模型 iAdipocytes1809 使我们能够在全基因组范围内深入了解脂肪细胞代谢的机制,并可作为整合组学数据的支架,以了解肥胖个体的基因型-表型关系。通过整合人类转录组和通量组数据,我们发现与瘦个体相比,肥胖个体的代谢活性在雄甾酮、神经节苷脂 GM2 和硫酸乙酰肝素和硫酸角质素的降解产物周围增加,而线粒体代谢活性降低。我们的研究通过将高通量患者数据与代谢建模相结合,为治疗肥胖症确定新的治疗靶点提供了一条途径。